Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nishant Sawant"'
Autor:
David, McAdams, Marcus, Estrada, David, Holland, Jasneet, Singh, Nishant, Sawant, John M, Hickey, Prashant, Kumar, Brian, Plikaytis, Sangeeta B, Joshi, David B, Volkin, Robert, Sitrin, Stan, Cryz, Jessica A, White
Publikováno v:
Vaccine. 40:5069-5078
Rotavirus infections remain a leading cause of morbidity and mortality among infants residing in low- and middle-income countries. To address the large need for protection from this vaccine-preventable disease we are developing a trivalent subunit ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5664364a7575359ba1b564cd80293b11
https://doi.org/10.1016/j.vaccine.2022.07.017
https://doi.org/10.1016/j.vaccine.2022.07.017
Autor:
J. Christopher Love, John M. Hickey, David D. Weis, Kerry R. Love, Joseph R. Brady, Sanjeev Agarwal, Nishant Sawant, David B. Volkin, Mary Kate Tracey, Kawaljit Kaur, Jian Xiong, David A. Holland, Sangeeta B. Joshi, Neil C. Dalvie, Tarit Mukhopadhyay
Publikováno v:
Journal of Pharmaceutical Sciences
In a companion paper, a two-step developability assessment is presented to rapidly evaluate low-cost formulations (multi-dose, aluminum-adjuvanted) for new subunit vaccine candidates. As a case study, a non-replicating rotavirus (NRRV) recombinant pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e2ff4fa158cb685c1de46cd1f1d053
https://doi.org/10.1016/j.xphs.2020.11.033
https://doi.org/10.1016/j.xphs.2020.11.033
Autor:
David B. Volkin, Moo Sun Hong, Richard D. Braatz, Sangeeta B. Joshi, Nishant Sawant, Kawaljit Kaur
Publikováno v:
Biotechnology and Bioengineering
Nonreplicating rotavirus vaccine (NRRV) candidates are being developed with the aim of serving the needs of developing countries. A significant proportion of the cost of manufacturing such vaccines is the purification in multiple chromatography steps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80b2da2b1c1204b397c5a594743482f
http://europepmc.org/articles/PMC8248096
http://europepmc.org/articles/PMC8248096
Publikováno v:
Journal of pharmaceutical sciences. 111(4)
Eight antimicrobial preservatives used in parenteral multidose formulations (thimerosal, 2-phenoxy ethanol, phenol, benzyl alcohol, m-cresol, chlorobutanol, methyl paraben, propyl paraben) were examined for their effects on the storage stability (4°
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa6c207cb51c32c34058175c008aad6
https://pubmed.ncbi.nlm.nih.gov/34758340
https://pubmed.ncbi.nlm.nih.gov/34758340
Autor:
Jian Xiong, Andrew B. Ward, Max Medina-Ramírez, John M. Hickey, Wen-Hsin Lee, Sangeeta B. Joshi, Neal Whitaker, Albert Cupo, Gabriel Ozorowski, Antu K. Dey, Nishant Sawant, John P. Moore, Rogier W. Sanders, David B. Volkin, Kawaljit Kaur
Publikováno v:
Journal of Pharmaceutical Sciences
Journal of pharmaceutical sciences, 108(7), 2264-2277. John Wiley and Sons Inc.
Journal of pharmaceutical sciences, 108(7), 2264-2277. John Wiley and Sons Inc.
The induction of broadly neutralizing antibodies (bNAbs) is a major goal in the development of an effective vaccine against HIV-1. A soluble, trimeric, germline (gI) bNAb-targeting variant of the HIV-1 envelope glycoprotein (termed BG505 SOSIP.v4.1-G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::738744c7c0ea2ed0a7a21cf07a63eb61
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85062594831&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85062594831&origin=inward